Get the Stockscreener App
21.53
1.96%
-0.4307
Mbx Biosciences Inc stock is traded at $21.53, with a volume of 102.56K.
It is down -1.96% in the last 24 hours and up +29.00% over the past month.
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
See More
Previous Close:
$21.96
Open:
$21.96
24h Volume:
102.56K
Relative Volume:
0.08
Market Cap:
$724.28M
Revenue:
-
Net Income/Loss:
$-47.20M
P/E Ratio:
-13.75
EPS:
-1.5653
Net Cash Flow:
$-43.65M
1W Performance:
+23.45%
1M Performance:
+29.00%
6M Performance:
+79.42%
1Y Performance:
-4.14%
1-Day Range:
$21.43
$22.40
1-Week Range:
$16.95
$22.53
52-Week Range:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Name
Mbx Biosciences Inc
Sector
Industry
Phone
(317) 989-3100
Address
11711 N. MERIDIAN STREET, CARMEL
Compare MBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
21.56 | 981.95M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.44 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.71 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.80 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.56 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.88 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-25 | Initiated | Truist | Buy |
| Aug-15-25 | Resumed | Jefferies | Buy |
| Aug-05-25 | Initiated | Mizuho | Outperform |
| Jul-16-25 | Initiated | Oppenheimer | Outperform |
| Apr-10-25 | Initiated | Citizens JMP | Mkt Outperform |
| Oct-08-24 | Initiated | Guggenheim | Buy |
| Oct-08-24 | Initiated | JP Morgan | Overweight |
| Oct-08-24 | Initiated | Jefferies | Buy |
| Oct-08-24 | Initiated | Stifel | Buy |
View All
Mbx Biosciences Inc Stock (MBX) Latest News
Using flow based indicators on MBX Biosciences Inc.2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Sentiment analysis tools applied to MBX Biosciences Inc.2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
What Wall Street predicts for MBX Biosciences Inc. stock priceVolume Spike & Pattern Based Trade Signal System - newser.com
What sentiment indicators say about MBX Biosciences Inc. stock2025 Trade Ideas & High Conviction Investment Ideas - newser.com
How rising interest rates impact MBX Biosciences Inc. stockAnalyst Upgrade & Short-Term High Return Strategies - newser.com
How to interpret RSI for MBX Biosciences Inc. stockJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
What indicators show strength in MBX Biosciences Inc.Portfolio Update Report & Proven Capital Preservation Methods - newser.com
Why MBX Biosciences Inc. stock remains on buy listsMarket Sentiment Report & Free Daily Entry Point Trade Alerts - newser.com
Is MBX Biosciences Inc. stock positioned for long term growth2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
Does MBX Biosciences Inc. fit your quant trading modelJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com
Detecting price anomalies in MBX Biosciences Inc. with AIEntry Point & High Return Trade Guides - newser.com
What technical signals suggest for MBX Biosciences Inc. stockJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - newser.com
Can MBX Biosciences Inc. hit a new high this monthOptions Play & Weekly Chart Analysis and Guides - newser.com
MBX Biosciences Inc. stock trend outlook and recovery pathJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
Published on: 2025-11-01 03:05:26 - newser.com
Published on: 2025-10-31 05:55:09 - newser.com
What machine learning models say about MBX Biosciences Inc.Earnings Trend Report & Precise Swing Trade Entry Alerts - newser.com
Relative strength of MBX Biosciences Inc. in sector analysisQuarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
Why MBX Biosciences Inc. stock is favored by pension fundsEarnings Performance Report & Fast Entry Momentum Trade Alerts - newser.com
Using fundamentals and technicals on MBX Biosciences Inc.2025 Historical Comparison & Risk Controlled Daily Plans - newser.com
Predicting MBX Biosciences Inc. trend using moving averages2025 Price Targets & Long-Term Capital Growth Strategies - newser.com
Visualizing MBX Biosciences Inc. stock with heatmaps2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
MBX Biosciences (NASDAQ:MBX) Trading Up 9.2%What's Next? - MarketBeat
Wall Street Analysts Think MBX Biosciences, Inc. (MBX) Could Surge 228.51%: Read This Before Placing a Bet - sharewise.com
Aug Drivers: Is MBX Biosciences Inc. stock positioned for digital transformationEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - fcp.pa.gov.br
Mbx Biosciences Inc Stock (MBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):